US Stock Market Move | Eli Lilly (LLY.US) rose more than 5.4% and its stock price reached a new all-time high.

On Monday, Eli Lilly & Company's (LLY.US) stock price reached a historical high of $981.99. As of the time of writing, the stock has risen over 5.4% to $974.415. In terms of news, Goldman Sachs Group, Inc. stated that an agreement to significantly reduce drug monthly fees has successfully unlocked the previously uncertain market of tens of millions of patients with insurance and medical subsidies. This indicates the huge potential for sales growth, maintaining a forecast of a $95 billion market size by 2030. Eli Lilly has taken advantage of higher market share and early market entry with oral drugs, while Novo Nordisk A/S Sponsored ADR Class B faces multiple growth pressures, with potential price disadvantages expanding to 18% in 2027 IRA negotiations.